Sivan Sapoznik

960 total citations
17 papers, 775 citations indexed

About

Sivan Sapoznik is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Sivan Sapoznik has authored 17 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Sivan Sapoznik's work include Radiopharmaceutical Chemistry and Applications (5 papers), Peptidase Inhibition and Analysis (5 papers) and Cell Adhesion Molecules Research (4 papers). Sivan Sapoznik is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Peptidase Inhibition and Analysis (5 papers) and Cell Adhesion Molecules Research (4 papers). Sivan Sapoznik collaborates with scholars based in Israel, United States and Germany. Sivan Sapoznik's co-authors include Orly Reiner, Tamar Sapir, Talia Levy, Rona Ortenberg, Gal Markel, Indraneel Ghosh, Anat Shmueli, Michal J. Besser, Jacob Schachter and Camila Avivi and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Sivan Sapoznik

17 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sivan Sapoznik Israel 16 349 207 192 153 131 17 775
Nicole Vincent Jordan United States 9 460 1.3× 154 0.7× 187 1.0× 78 0.5× 193 1.5× 10 906
Jimmy Elliott United States 11 434 1.2× 167 0.8× 92 0.5× 193 1.3× 40 0.3× 15 733
Jacqueline Perreau France 7 337 1.0× 233 1.1× 108 0.6× 186 1.2× 38 0.3× 11 762
Maura Sonego Italy 14 600 1.7× 303 1.5× 83 0.4× 115 0.8× 20 0.2× 18 937
Adrienne Brown United States 14 478 1.4× 143 0.7× 47 0.2× 228 1.5× 124 0.9× 26 977
Amir H. Salehi Canada 8 594 1.7× 82 0.4× 76 0.4× 273 1.8× 28 0.2× 13 873
Marie‐Hélène Buc‐Caron France 19 665 1.9× 56 0.3× 104 0.5× 239 1.6× 37 0.3× 26 931
Mordechai Anafi Canada 13 628 1.8× 199 1.0× 212 1.1× 224 1.5× 48 0.4× 16 1.1k
Ina Kalus Germany 16 590 1.7× 67 0.3× 525 2.7× 146 1.0× 29 0.2× 18 965
JrGang Cheng United States 14 322 0.9× 107 0.5× 75 0.4× 182 1.2× 16 0.1× 17 800

Countries citing papers authored by Sivan Sapoznik

Since Specialization
Citations

This map shows the geographic impact of Sivan Sapoznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivan Sapoznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivan Sapoznik more than expected).

Fields of papers citing papers by Sivan Sapoznik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivan Sapoznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivan Sapoznik. The network helps show where Sivan Sapoznik may publish in the future.

Co-authorship network of co-authors of Sivan Sapoznik

This figure shows the co-authorship network connecting the top 25 collaborators of Sivan Sapoznik. A scholar is included among the top collaborators of Sivan Sapoznik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivan Sapoznik. Sivan Sapoznik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ortenberg, Rona, Sivan Sapoznik, Douglas Zippel, et al.. (2015). Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. Journal of Immunology Research. 2015. 1–8. 12 indexed citations
2.
Ortenberg, Rona, Gilli Galore-Haskel, Sivan Sapoznik, et al.. (2014). CEACAM1 Promotes Melanoma Cell Growth through Sox-2. Neoplasia. 16(5). 451–460. 32 indexed citations
3.
Bahar‐Shany, Keren, Sivan Sapoznik, Jasmine Jacob‐Hirsch, et al.. (2013). Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma. Gynecologic Oncology. 132(2). 322–327. 72 indexed citations
4.
Levanon, Keren, Sivan Sapoznik, Keren Bahar‐Shany, et al.. (2013). FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis. Oncogene. 33(35). 4424–4432. 24 indexed citations
5.
Ortenberg, Rona, Liat Hershkovitz, Sivan Sapoznik, et al.. (2012). Novel Immunotherapy for Malignant Melanoma with a Monoclonal Antibody That Blocks CEACAM1 Homophilic Interactions. Molecular Cancer Therapeutics. 11(6). 1300–1310. 59 indexed citations
6.
Sapoznik, Sivan, et al.. (2012). CEACAM1 in Malignant Melanoma: A Diagnostic and Therapeutic Target. Current Topics in Medicinal Chemistry. 12(1). 3–10. 21 indexed citations
7.
Sapoznik, Sivan, Rona Ortenberg, Gilli Galore-Haskel, et al.. (2012). CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy. Cancer Immunology Immunotherapy. 61(10). 1833–1847. 39 indexed citations
8.
Sapoznik, Sivan, Rona Ortenberg, Tamar Hamburger, et al.. (2012). Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients. SHILAP Revista de lepidopterología. 2012. 1–8. 25 indexed citations
9.
Sapoznik, Sivan, Rona Ortenberg, Michal J. Besser, et al.. (2012). Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms. SHILAP Revista de lepidopterología. 2012. 1–9. 19 indexed citations
10.
Shmueli, Anat, Tamar Sapir, Ryouhei Tsutsumi, et al.. (2009). Ndel1 palmitoylation: a new mean to regulate cytoplasmic dynein activity. The EMBO Journal. 29(1). 107–119. 44 indexed citations
11.
Markel, Gal, Rona Ortenberg, Rachel Seidman, et al.. (2009). Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunology Immunotherapy. 59(2). 215–230. 53 indexed citations
12.
Sapir, Tamar, Sivan Sapoznik, Talia Levy, et al.. (2008). Accurate Balance of the Polarity Kinase MARK2/Par-1 Is Required for Proper Cortical Neuronal Migration. Journal of Neuroscience. 28(22). 5710–5720. 82 indexed citations
13.
Shmueli, Anat, et al.. (2006). Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1). Molecular and Cellular Neuroscience. 32(1-2). 15–26. 39 indexed citations
14.
Reiner, Orly, Sivan Sapoznik, & Tamar Sapir. (2006). Lissencephaly 1 Linking to Multiple Diseases: Mental Retardation, Neurodegeneration, Schizophrenia, Male Sterility, and More. NeuroMolecular Medicine. 8(4). 547–566. 26 indexed citations
15.
Polak, Pazit, et al.. (2005). The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene. 25(5). 665–676. 21 indexed citations
16.
Ghosh, Indraneel, et al.. (2004). DCX, a new mediator of the JNK pathway. The EMBO Journal. 23(4). 823–832. 179 indexed citations
17.
Reiner, Orly, Indraneel Ghosh, Talia Levy, et al.. (2004). DCXs Phosphorylation by Not Just aNother Kinase (JNK). Cell Cycle. 3(6). 745–749. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026